{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:23:39Z","timestamp":1788279819895,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/maj.0b013e318065c254","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T08:06:37Z","timestamp":1181289997000},"page":"321-326","source":"Crossref","is-referenced-by-count":46,"title":["Azelnidipine Reduces Urinary Protein Excretion and Urinary Liver-Type Fatty Acid Binding Protein in Patients with Hypertensive Chronic Kidney Disease"],"prefix":"10.1016","volume":"333","author":[{"given":"Tsukasa","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kawagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e318065c254_bb0010","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/jpet.105.095331","article-title":"Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats","volume":"316","author":"Kondo","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0015","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1111\/j.1523-1755.2005.09426.x","article-title":"Mechanisms of tubulointerstitial injury in IgA nephropathy","volume":"94","author":"Lai","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lab.2003.08.001","article-title":"Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease","volume":"143","author":"Kamijo","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000441-200510000-00002","article-title":"Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease","volume":"330","author":"Nakamura","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000087826","article-title":"Urinary liver-type fatty acid binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy","volume":"25","author":"Nakamura","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0035","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/diacare.28.11.2728","article-title":"Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy","volume":"28","author":"Nakamura","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpba.2004.04.016","article-title":"Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy","volume":"36","author":"Xu","year":"2004","journal-title":"J Pharm Biomed Anal"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1442-200X.2006.02156.x","article-title":"Urinary oxidative stress markers in young patients with type 1 diabetes","volume":"48","author":"Hata","year":"2006","journal-title":"Pediatr Int"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/147323000403200210","article-title":"Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells","volume":"32","author":"Shinomiya","year":"2004","journal-title":"J Int Med Res"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0055","first-page":"39","article-title":"Quantitive determination of urinary 8-hydroxy deoxyguanosine (8-OHdG) by using ELISA","volume":"107","author":"Saito","year":"2000","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/biof.5520220150","article-title":"Quantitative determination of urinary 8-hydroxy-2'-deoxyguanosine level in healthy Japanese volunteers","volume":"22","author":"Miwa","year":"2004","journal-title":"Biofactors"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0065","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/01.ASN.0000138287.46849.82","article-title":"Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells","volume":"15","author":"Tanaka","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0070","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/01.ASN.0000128047.13396.48","article-title":"Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis","volume":"15","author":"Matsumoto","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0075","first-page":"111","article-title":"Renoprotective effects of azelnidipine by improvement of renal microcirculation","volume":"30","author":"Fujimoto","year":"2004","journal-title":"Kawasaki Igakkaishi"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lab.2004.12.003","article-title":"Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial","volume":"145","author":"Kamijo","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0085","doi-asserted-by":"crossref","unstructured":". Kamijo A, Sugaya T, Hikawa A, et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem, in press.","DOI":"10.1007\/s11010-005-9047-9"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000058412","article-title":"Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy","volume":"91","author":"Kanauchi","year":"2002","journal-title":"Nephron"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mehy.2004.12.007","article-title":"Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist","volume":"65","author":"Nakamura","year":"2005","journal-title":"Med Hypothesis"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.ASN.0000125614.35046.10","article-title":"Evidence of tubular hypoxia in the early phase in the remnant kidney model","volume":"15","author":"Manotham","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1681\/ASN.2004100852","article-title":"Chronic angiotensin II receptor blockade reduces intrarenal vascular resistance in patients with type 2 diabetes","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0110","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1681\/ASN.2005050571","article-title":"Fluvastatin ameliorates podocyte injury in proteinuria rats via modulation of excessive Rho signaling","volume":"17","author":"Shibata","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjcard.2005.09.110","article-title":"Effects of statins on renal function","volume":"97","author":"Agarwal","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1097\/MAJ.0b013e318065c254_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000091956","article-title":"Effect of pitavastatin on urinary liver-type fatty acid binding protein in patients with nondiabetic mild chronic kidney disease","volume":"26","author":"Nakamura","year":"2006","journal-title":"Am J Nephrol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915325477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915325477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T21:01:45Z","timestamp":1556485305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915325477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0002962915325477"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e318065c254","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}